首页> 外国专利> QUALITATIVE DIFFERENTIAL INSTANT DIAGNOSTIC TECHNIQUE FOR PERIGLOTTIS GROWTHS SHOWN BY PATIENT'S ORAL FLUID BIOMARKERS

QUALITATIVE DIFFERENTIAL INSTANT DIAGNOSTIC TECHNIQUE FOR PERIGLOTTIS GROWTHS SHOWN BY PATIENT'S ORAL FLUID BIOMARKERS

机译:患者口腔流体生物标记物对定性的眼周生长的定性差速即时诊断技术

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely to qualitative differential instant diagnostic technique for benign and malignant periglottis new growths as shown by oral fluid biomarkers. Substance of the method consists in measuring a quantity of matrix metalloproteinase 2 (MMP 2) in patient's oral fluid; the clinical reference is the level of 1.7-2.9 ng/ml; if the MMP 2 content is 14.4-24.3 ng/ml, patient's periglottis papilloma is diagnosed; if the patient's oral fluid MMP 2 content is 4.1-6.8 ng/ml, periglottis cancer is diagnosed. A biomarker for the qualitative differential instant diagnosis of the periglottis new growths is a tissue inhibitor of metalloproteinase 2 (TIMP 2); the clinical reference is a level of 6.44-11.23 ng/ml; if the TIMP 2 content 29.25-48.75 ng/ml, patient's periglottis papilloma is diagnosed; the TIMP 2 content being 57.23-95.03 ng/ml, periglottis cancer is diagnosed.;EFFECT: using the declared technique enables providing more accurate differential diagnosis of the benign and malignant periglottis new growths.;2 cl, 6 ex
机译:技术领域本发明涉及医学,即口服液体生物标志物所显示的用于良性和恶性的食指新生长的定性差异即时诊断技术。该方法的实质在于测量患者口腔液中基质金属蛋白酶2(MMP 2)的含量;临床参考水平为1.7-2.9 ng / ml;如果MMP 2含量为14.4-24.3 ng / ml,则诊断为患者的眼周乳头状瘤。如果患者的口腔液中MMP 2含量为4.1-6.8 ng / ml,则诊断为会厌癌。定性鉴别出眼周新生长的生物标志物是金属蛋白酶2(TIMP 2)的组织抑制剂。临床参考水平为6.44-11.23 ng / ml;如果TIMP 2含量为29.25-48.75 ng / ml,则诊断出患者的眼周乳头状瘤。 ; TIMP 2含量为57.23-95.03 ng / ml,诊断为百日咳癌。效果:使用已宣布的技术能够对良性和恶性的百日咳新生长情况提供更准确的鉴别诊断; 2 cl,6 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号